To maintain its position as a leader in the health-care field, Britain should hold onto major companies in the preserving life category.
But its share of companies in R & D is in decline, boasting of major figures in the field. The way in which new drugs are approved might be a starting point for reform. Let discussions between the government and the industry should alleviate major problems and let Britain service its citizens with top quality health care!
My opinion.
No comments:
Post a Comment